Share this publication:
RibC was successfully cloned, and heterologously expressed in E. coli. The produced protein was biochemically proven to be involved in the conversion of Glucose 6 phosphate (G 6 p) to 2 deoxy scyllo inosose. RibN was proven to have an endogenous frame shift mutation which was proposed to be the reason for the formation of ribostamycin as an end product instead of neomycin.RibN was cloned into pUWL201PW shuttle vector as a prerequisite step for its influence on ribostamycin production.
About the publisher:
iMedPub Limited is a publishing house registered in UK, publishing medical books and journals since 2005. As an open service to doctors and biomedical researchers, it is driven by clinicians and researchers for themselves, while serving the interests of the general public. iMedPub disseminates research in a tiered system, beginning with our specialty books and journals and then working upwards. The grand vision of iMedPub is a world where all medical researchers and health professionals have an equal opportunity to seek, share and create knowledge. As we are a low cost academic publisher we offer the lowest article processing charges of all biomedical journals and publish books free of charges for authors.